Medicines, Poisons and Therapeutic Goods Regulation 2008
533AStorage of buprenorphine or methadone by opioid
Start here
Get a plain-English read of 533A
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2008.
533A Storage of buprenorphine or methadone by opioid dependency treatment licence-holders etc—Act, s 61 (b) and (c) (1) This section applies to a pharmacist authorised under an opioid dependency treatment licence to possess buprenorphine or methadone. (2) Despite section 533, the pharmacist may, during the business hours for the pharmacy to which the opioid dependency treatment licence relates, store buprenorphine or methadone that is not for immediate administration in a medicines cupboard or drawer if— (a) the medicines cupboard or drawer is securely fixed to a wall or floor (or both); and (b) the medicines cupboard or drawer is kept securely locked when not in immediate use; and (c) the medicines cupboard or drawer is under the direct supervision of the pharmacist at all times the medicines cupboard or drawer contains buprenorphine or methadone; and (d) for a medicines cupboard or drawer that is unlocked by a combination lock—the pharmacist keeps the combination confidential; and (e) for a medicines cupboard or drawer that is unlocked by a key— the pharmacist keeps personal custody of the key; and (f) the door of the medicines cupboard or drawer is not in direct view of a member of the public attending the pharmacy.